| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2008 | APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese | Chien K.-L.; Fang W.-H.; Wen H.-C.; Lin H.-P.; Lin Y.-L.; SHU-WHA LIN ; Wu J.-H.; Kao J.-T. | Clinica Chimica Acta | 35 | 31 | |
| 2008 | APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese | Chien K.-L.; WOEI-HORNG FANG ; Wen H.-C.; Lin H.-P.; Lin Y.-L.; Lin S.-W.; Wu J.-H.; Kao J.-T. | Clinica Chimica Acta | 31 | 31 | |
| 2008 | APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese | KUO-LIONG CHIEN ; Fang W.-H.; Wen H.-C.; Lin H.-P.; Lin Y.-L.; Lin S.-W.; Wu J.-H.; Kao J.-T. | Clinica Chimica Acta | 31 | ||
| 2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | Chang S.-Y.; Ko W.-S.; Kao J.-T.; Chang L.-Y.; Sun H.-Y.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; CHUAN-LIANG KAO ; Lee C.-N.; Hung C.-C.; Chang S.-C. | Clinical Infectious Diseases | 18 | 15 | |
| 2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | Chang S.-Y.; Ko W.-S.; Kao J.-T.; Chang L.-Y.; Sun H.-Y.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; Kao C.-L.; Lee C.-N.; CHIEN-CHING HUNG ; Chang S.-C. | Clinical Infectious Diseases | 18 | 15 | |
| 2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | Chang S.-Y.; Ko W.-S.; Kao J.-T.; Chang L.-Y.; Sun H.-Y.; Chen M.-Y.; Hsieh S.-M.; WANG-HUEI SHENG ; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; Kao C.-L.; Lee C.-N.; Hung C.-C.; Chang S.-C. | Clinical Infectious Diseases | 18 | 15 | |
| 2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | SUI-YUAN CHANG ; Ko W.-S.; Kao J.-T.; Chang L.-Y.; Sun H.-Y.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; Kao C.-L.; Lee C.-N.; Hung C.-C.; Chang S.-C. | Clinical Infectious Diseases | 17 | 15 | |
| 2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | Chang S.-Y.; Ko W.-S.; Kao J.-T.; Chang L.-Y.; HSIN-YUN SUN ; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; Kao C.-L.; Lee C.-N.; Hung C.-C.; Chang S.-C. | Clinical Infectious Diseases | 18 | 15 | |
| 2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | Chang S.-Y.; Ko W.-S.; Kao J.-T.; Chang L.-Y.; Sun H.-Y.; Chen M.-Y.; SZU-MIN HSIEH ; Sheng W.-H.; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; Kao C.-L.; Lee C.-N.; Hung C.-C.; Chang S.-C. | Clinical Infectious Diseases | 18 | 15 | |
| 2009 | Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan | Chang S.-Y.; Ko W.-S.; Kao J.-T.; Chang L.-Y.; Sun H.-Y.; Chen M.-Y.; Hsieh S.-M.; Sheng W.-H.; Chang S.-F.; Liu W.-C.; Wu C.-H.; Hsu H.-J.; Kao C.-L.; Lee C.-N.; Hung C.-C.; SHAN-CHWEN CHANG | Clinical Infectious Diseases | 18 | 15 | |
| 2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N.; Yang S.-J.; Shen M.-C.; Kao J.-T.; SHU-WHA LIN | Thrombosis and Haemostasis | 1 | 1 | |
| 2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N.; Yang S.-J.; MING-CHING SHEN ; Kao J.-T.; Lin S.-W. | Thrombosis and Haemostasis | 1 | ||
| 2011 | Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B | Kao C.-Y.; Lin C.-N.; YUNG-LI YANG ; Hamaguchi N.; Yang S.-J.; Shen M.-C.; Kao J.-T.; Lin S.-W. | Thrombosis and Haemostasis | 1 | 1 | |
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; CHIEH-CHANG CHEN ; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. | Scientific Reports | 15 | 13 | |
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; CHUN-JEN LIU ; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; Liu C.-H.; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. | Scientific Reports | 13 | ||
| 2017 | Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients | Lee M.-H.; Huang C.-F.; Lai H.-C.; Lin C.-Y.; Dai C.-Y.; Liu C.-J.; Wang J.-H.; Huang J.-F.; Su W.-P.; Yang H.-C.; Kee K.-M.; Yeh M.-L.; Chuang P.-H.; Hsu S.-J.; Huang C.-I.; Kao J.-T.; Chen C.-C.; Chen S.-H.; Jeng W.-J.; Yang H.-I.; Yuan Y.; Lu S.-N.; Sheen I.-S.; CHEN-HUA LIU ; Peng C.-Y.; Kao J.-H.; Yu M.-L.; Chuang W.-L.; Chen C.-J. | Scientific Reports | 13 | ||
| 2009 | Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment | Chien K.-L.; Lin Y.-L.; Wen H.-C.; Lin H.-P.; Yen C.-T.; SHU-WHA LIN ; Kao J.-T. | Pharmacogenomics | 6 | 5 | |
| 2009 | Common sequence variant in lipoprotein lipase gene conferring triglyceride response to fibrate treatment | KUO-LIONG CHIEN ; Lin Y.-L.; Wen H.-C.; Lin H.-P.; Yen C.-T.; Lin S.-W.; Kao J.-T. | Pharmacogenomics | 5 | ||
| 2007 | Comparison of three automated urinalysis systems-Bayer Clinitek Atlas, Roche Urisys 2400 and Arkray Aution Max for testing urine chemistry and detection of bacteriuria | Chien T.-I.; JIN-YING LU ; Kao J.-T.; Lee T.-F.; Ho S.-Y.; Chang C.-Y.; Liu C.-W.; Lee C.-H.; Yan S.-N.; Yang J.-Y.; Lin P.-C.; Wang M.-J. | Clinica Chimica Acta | 14 | 13 | |
| 2011 | Corrigendum to "Endonuclease V-mediated deoxyinosine excision repair in vitro" [DNA Repair 9 (2010) 1073-1079] | Lee C.-C.; Yang Y.-C.; Goodman S.D.; Yu Y.-H.; Lin S.-B.; Kao J.-T.; Tsai K.-S.; WOEI-HORNG FANG | DNA Repair | 0 | 0 |
